Total trials
209
Active
20
Phase 3
30
Total enrollment
60,448
Pipeline matrix
Showing 7 of 7 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Velcade | — | — | — | — | — | 1 | |
| Melphalan | — | — | — | — | — | 1 | |
| Prednisone | — | — | — | — | — | 1 | |
| Lenalidomide | — | — | — | — | — | 1 | |
| Dexamethasone | — | — | — | — | — | 1 | |
| Daratumumab | — | — | — | — | — | 1 | |
| Noradrenaline | — | — | — | — | — | 1 |
Next readouts
- 2026-03
- 2027-01-03
Top conditions
- Periodontitis10
- Periodontal Diseases6
- Multiple Myeloma5
- Insulin Resistance3
- Sepsis3
- Diabetes Mellitus, Type 23
- Gastroesophageal Reflux3
- Obesity3
Frequently asked questions about University of Turin, Italy
- How many clinical trials does University of Turin, Italy have on ClinicalTrials.gov?
- University of Turin, Italy is listed as the lead sponsor on 209 clinical trials in ClinicalTrials.gov, 20 of which are currently active (recruiting, enrolling, or ongoing).
- How many of University of Turin, Italy's trials are in Phase 3?
- 30 of University of Turin, Italy's trials are in Phase 3, spread across 7 active drug programs.
- What therapeutic areas does University of Turin, Italy focus on?
- University of Turin, Italy's most-studied conditions on ClinicalTrials.gov are Periodontitis, Periodontal Diseases, Multiple Myeloma, Insulin Resistance, Sepsis.
- When are University of Turin, Italy's next clinical trial readouts?
- University of Turin, Italy has 2 upcoming primary-completion readouts tracked here; the soonest is “Preventing Cardiovascular Collapse With Vasopressors During Tracheal Intubation”, expected around 2026-03.